title: Complications from radiotherapy.
abstract: Radiotherapy (RT) of the brain is associated with significant stigma in the neuro-oncology community. This is primarily because of the potentially severe complications with which it may be associated. These complications, especially in subacute and latent settings, are often unpredictable, potentially progressive, and irreversible. The onset of complications may start from the first fraction of 2 Gy, continuing over several months after end of RT with persistent drowsiness and apathy. It may also extend over many years with progressive onset of neurocognitive impairments such as memory decline, and diminished focus/attention. For long-term survivors, such as young patients irradiated for a favorable low-grade glioma, quality of life can be seriously impacted by RT. It is essential, as in the pediatric field, to propose patient-specific regimens from the very outset of therapy. The use of molecular biomarkers to better predict survival, control of comorbidities along with judicious use of medications such as steroids and antiepileptics, improved targeting with the help of modern imaging and RT techniques, modulation of the dose, and fractionation aimed at limiting integral dose to the healthy brain all have the potential to minimize treatment-related complications while maintaining the therapeutic efficacy for which RT is known. Sparing "radiosensitive" areas such as hippocampi could have a modest but measurable impact with regard to cognitive preservation, an effect that can possibly be enhanced when used in conjunction with memantine and/or donepezil.
authors.affiliation: Radiation Oncology Department, Gustave Roussy University Hospital, Villejuif, France. Electronic address: Frederic.dhermain@gustaveroussy.fr.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Dhermain
authors.affiliation: Department of Radiation Oncology, University of California San Francisco, San Francisco, CA, USA.
authors.forename: Igor J
authors.initials: IJ
authors.lastname: Barani
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy*; D005910:Glioma / Q000532:radiotherapy*; D006801:Humans; D011832:Radiation Injuries / Q000503:physiopathology*; D016634:Radiosurgery / Q000009:adverse effects*
keywords: cerebrovascular disease; conformal radiotherapy; drugs; leukoencephalopathy; neurocognition; quality of life; radionecrosis; radiosurgery; rehabilitation